Glyset

Glyset is a brand name of miglitol, approved by the FDA in the following formulation(s):

GLYSET (miglitol - tablet; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: December 18, 1996
  
  Strength(s): 100MG ^[RLD], 25MG, 50MG
  

Has a generic version of Glyset been approved?

No. There is currently no therapeutically equivalent version of Glyset available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Glyset. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Glyset.

See also...

• Glyset Consumer Information (Wolters Kluwer)
• Glyset Consumer Information (Cerner Multum)
• Glyset Advanced Consumer Information (Micromedex)
• Glyset AHFS DI Monographs (ASHP)
• Miglitol Consumer Information (Wolters Kluwer)
• Miglitol Consumer Information (Cerner Multum)
• Miglitol Advanced Consumer Information (Micromedex)
• Miglitol AHFS DI Monographs (ASHP)